Big roles of microRNAs in tumorigenesis and tumor development

Histology and Histopathology

Volumn 26, Issue 10, 2011, Pages 1353-1361

  Tie, Jun ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gene expression regulations; MicroRNAs; Neoplasms

Indexed keywords

MESSENGER RNA;

ANIMAL; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; NEOPLASM; REVIEW;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; RNA, MESSENGER;

EID: 80053335068     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Akao Y., Noguchi S., Iio A., Kojima K., Takagi T. and Naoe T. (2011). Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells. Cancer Lett 300, 197-204.
2. Alvarez-Garcia I. and Miska E.A. (2005). MicroRNA functions in animal development and human disease. Development 132, 4653-4662.
3. Baranwal S. and Alahari S.K. (2010). miRNA control of tumor cell invasion and metastasis. Int. J. Cancer 126, 1283-1290.
4. Bartel D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
5. Budhu A., Jia H.L., Forgues M., Liu C.G., Goldstein D., Lam A., Zanetti K.A., Ye Q.H., Qin L.X., Croce C.M., Tang Z.Y. and Wang X.W. (2008). Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47, 897-907.
6. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., Iorio M.V., Visone R., Sever N.I., Fabbri M., Iuliano R., Palumbo T., Pichiorri F., Roldo C., Garzon R., Sevignani C., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M. and Croce C.M. (2005). A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353, 1793-1801.
7. Chang T.C., Yu D., Lee Y.S., Wentzel E.A., Arking D.E., West K.M., Dang C.V., Thomas-Tikhonenko A. and Mendell J.T. (2008). Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 40, 43-50.
8. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., Li Q., Li X., Wang W., Wang J., Jiang X., Xiang Y., Xu C., Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Zen K. and Zhang C.Y. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997-1006.
9. Denli A.M., Tops B.B., Plasterk R.H., Ketting R.F. and Hannon G.J. (2004). Processing of primary microRNAs by the Microprocessor complex. Nature 432, 231-235.
10. Ding J., Huang S., Wu S., Zhao Y., Liang L., Yan M., Ge C., Yao J., Chen T., Wan D., Wang H., Gu J., Yao M., Li J., Tu H. and He X. (2010). Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat. Cell Biol. 12, 390-399.
11. Dumont N. and Tlsty T.D. (2009). Reflections on miR-ing effects in metastasis. Cancer Cell 16, 3-4.
12. Gardner P.P. and Vinther J. (2008). Mutation of miRNA target sequences during human evolution. Trends Genet. 24, 262-265.
13. Garofalo M., Quintavalle C., Di Leva G., Zanca C., Romano G., Taccioli C., Liu C.G., Croce C.M. and Condorelli G. (2008). MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene 27, 3845-3855.
14. He H., Jazdzewski K., Li W., Liyanarachchi S., Nagy R., Volinia S., Calin G.A., Liu C.G., Franssila K., Suster S., Kloos R.T., Croce C.M. and de la Chapelle A. (2005). The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. USA 102, 19075-19080.
15. Hornstein E., Mansfield J.H., Yekta S., Hu J.K., Harfe B.D., McManus M.T., Baskerville S., Bartel D.P. and Tabin C.J. (2005). The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development. Nature 438, 671-674.
16. Hua Z., Lv Q., Ye W., Wong C.K., Cai G., Gu D., Ji Y., Zhao C., Wang J., Yang B.B. and Zhang Y. (2006). MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE 1, e116.
17. Huang Q., Gumireddy K., Schrier M., le Sage C., Nagel R., Nair S., Egan D.A., Li A., Huang G., Klein-Szanto A.J., Gimotty P.A., Katsaros D., Coukos G., Zhang L., Pure E. and Agami R. (2008). The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol 10, 202-210.
18. Hutvagner G., McLachlan J., Pasquinelli A.E., Balint E., Tuschl T. and Zamore P.D. (2001). A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834-838.
19. Ji Q., Hao X., Meng Y., Zhang M., Desano J., Fan D. and Xu L. (2008). Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 8, 266.
20. Khew-Goodall Y. and Goodall G.J. (2010). Myc-modulated miR-9 makes more metastases. Nat. Cell Biol. 12, 209-211.
21. Kovalchuk O., Filkowski J., Meservy J., Ilnytskyy Y., Tryndyak V.P., Chekhun V.F. and Pogribny I.P. (2008). Involvement of microRNA- 451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol. Cancer Ther. 7, 2152-2159.
22. Kumar M.S., Lu J., Mercer K.L., Golub T.R. and Jacks T. (2007). Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet 39, 673-677.
23. Lagos-Quintana M., Rauhut R., Lendeckel W. and Tuschl T. (2001). Identification of novel genes coding for small expressed RNAs. Science 294, 853-858.
24. Lawrie C.H., Gal S., Dunlop H.M., Pushkaran B., Liggins A.P., Pulford K., Banham A.H., Pezzella F., Boultwood J., Wainscoat J.S., Hatton C.S. and Harris A.L. (2008). Detection of elevated levels of tumourassociated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 141, 672-675.
25. Lee R.C., Feinbaum R.L. and Ambros V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854.
26. Lee Y., Jeon K., Lee J.T., Kim S. and Kim V.N. (2002). MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21, 4663-4670.
27. Lee Y., Yang X., Huang Y., Fan H., Zhang Q., Wu Y., Li J., Hasina R., Cheng C., Lingen M.W., Gerstein M.B., Weichselbaum R.R., Xing H.R. and Lussier Y.A. (2010). Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. PLoS Comput Biol 6, e1000730.
28. Li X., Zhang Y., Ding J., Wu K. and Fan D. (2010). Survival prediction of gastric cancer by a seven-microRNA signature. Gut 59, 579-585.
29. Li Y., Vandenboom T.G. 2nd, Wang Z., Kong D., Ali S., Philip P.A. and Sarkar F.H. (2010). MiR-146a suppresses invasion of pancreatic cancer cells. Cancer Res 70, 1486-1495.
30. Llave C., Xie Z., Kasschau K.D. and Carrington J.C. (2002). Cleavage of Scarecrow-like mRNA targets directed by a class of Arabidopsis miRNA. Science 297, 2053-2056.
31. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R. and Golub T.R. (2005). MicroRNA expression profiles classify human cancers. Nature 435, 834-838.
32. Lwin T., Lin J., Choi Y.S., Zhang X., Moscinski L.C., Wright K.L., Sotomayor E.M., Dalton W.S. and Tao J. (2010). Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a. Blood 116, 5228-5236.
33. Ma J., Dong C. and Ji C. (2010). MicroRNA and drug resistance. Cancer Gene Ther 17, 523-531.
34. Ma L. and Weinberg R.A. (2008). Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet 24, 448-456.
35. Ma L., Teruya-Feldstein J. and Weinberg R.A. (2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688.
36. Ma L., Young J., Prabhala H., Pan E., Mestdagh P., Muth D., Teruya-Feldstein J., Reinhardt F., Onder T.T., Valastyan S., Westermann F., Speleman F., Vandesompele J. and Weinberg R.A. (2010). MiR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 12, 247-256.
37. Miller T.E., Ghoshal K., Ramaswamy B., Roy S., Datta J., Shapiro C.L., Jacob S. and Majumder S. (2008). MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J. Biol. Chem. 283, 29897-29903.
38. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentleman R., Vessella R.L., Nelson P.S., Martin D.B. and Tewari M. (2008). Circulating microRNAs as stable bloodbased markers for cancer detection. Proc. Natl. Acad. Sci. USA 105, 10513-10518.
39. Nicoloso M.S., Spizzo R., Shimizu M., Rossi S. and Calin G.A. (2009). MicroRNAs--the micro steering wheel of tumour metastases. Nat. Rev. Cancer 9, 293-302.
40. Palatnik J.F., Allen E., Wu X., Schommer C., Schwab R., Carrington J.C. and Weigel D. (2003). Control of leaf morphogenesis by microRNAs. Nature 425, 257-263.
41. Pillai R.S., Bhattacharyya S.N., Artus C.G., Zoller T., Cougot N., Basyuk E., Bertrand E. and Filipowicz W. (2005). Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309, 1573-1576.
42. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., Horvitz H.R. and Ruvkun G. (2000). The 21- nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901-906.
43. Resnick K.E., Alder H., Hagan J.P., Richardson D.L., Croce C.M. and Cohn D.E. (2009). The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol. 112, 55-59.
44. Rodriguez A., Griffiths-Jones S., Ashurst J.L. and Bradley A. (2004). Identification of mammalian microRNA host genes and transcription units. Genome Res. 14, 1902-1910.
45. Sachdeva M. and Mo Y.Y. (2010). MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res. 70, 378-387.
46. Santarpia L., Nicoloso M. and Calin G.A. (2010). MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype. Endocr. Relat. Cancer 17, F51-F75.
47. Schmittgen T.D. (2010). MiR-31: a master regulator of metastasis? Future Oncol. 6, 17-20.
48. Sengupta S., den Boon J.A., Chen I.H., Newton M.A., Stanhope S.A., Cheng Y.J., Chen C.J., Hildesheim A., Sugden B. and Ahlquist P. (2008). MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc. Natl. Acad. Sci. USA 105, 5874-5878.
49. Si M.L., Zhu S., Wu H., Lu Z., Wu F. and Mo Y.Y. (2007). MiR-21-mediated tumor growth. Oncogene 26, 2799-2803.
50. Tabara H., Sarkissian M., Kelly W.G., Fleenor J., Grishok A., Timmons L., Fire A. and Mello C.C. (1999). The rde-1 gene, RNA interference, and transposon silencing in C. elegans. Cell 99, 123-132.
51. Tavazoie S.F., Alarcon C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L. and Massague J. (2008). Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147-152.
52. Tian Y., Luo A., Cai Y., Su Q., Ding F., Chen H. and Liu Z. (2010). MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J. Biol. Chem. 285, 7986-7994.
53. Tie J., Pan Y., Zhao L., Wu K., Liu J., Sun S., Guo X., Wang B., Gang Y., Zhang Y., Li Q., Qiao T., Zhao Q., Nie Y. and Fan D. (2010). MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet. 6, e1000879.
54. Valastyan S., Chang A., Benaich N., Reinhardt F. and Weinberg R.A. (2010). Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis. Cancer Res. 70, 5147-5154.
55. Valastyan S., Reinhardt F., Benaich N., Calogrias D., Szasz A.M., Wang Z.C., Brock J.E., Richardson A.L. and Weinberg R.A. (2009). A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137, 1032-1046.
56. Valastyan S. and Weinberg R.A. (2010). MiR-31: A crucial overseer of tumor metastasis and other emerging roles. Cell Cycle 9,
57. Venturini L., Battmer K., Castoldi M., Schultheis B., Hochhaus A., Muckenthaler M.U., Ganser A., Eder M. and Scherr M. (2007). Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 109, 4399-4405.
58. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C. and Croce C.M. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103, 2257-2261.
59. Voorhoeve P.M., le Sage C., Schrier M., Gillis A.J., Stoop H., Nagel R., Liu Y.P., van Duijse J., Drost J., Griekspoor A., Zlotorynski E., Yabuta N., De Vita G., Nojima H., Looijenga L.H. and Agami R. (2006). A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124, 1169-1181.
60. Wang Q., Li Y.C., Wang J., Kong J., Qi Y., Quigg R.J. and Li X. (2008). MiR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130. Proc. Natl. Acad. Sci. USA 105, 2889-2894.
61. Weiss G.J., Bemis L.T., Nakajima E., Sugita M., Birks D.K., Robinson W.A., Varella-Garcia M., Bunn P.A. Jr., Haney J., Helfrich B.A., Kato H., Hirsch F.R. and Franklin W.A. (2008). EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann. Oncol. 19, 1053-1059.
62. Wightman B., Ha I. and Ruvkun G. (1993). Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75, 855-862.
63. Wu Q., Jin H., Yang Z., Luo G., Lu Y., Li K., Ren G., Su T., Pan Y., Feng B., Xue Z., Wang X. and Fan D. (2010). MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem. Biophys. Res. Commun. 392, 340-345.
64. Xia L., Zhang D., Du R., Pan Y., Zhao L., Sun S., Hong L., Liu J. and Fan D. (2008). MiR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer 123, 372-379.
65. Zhang H., Li Y. and Lai M. (2010). The microRNA network and tumor metastasis. Oncogene 29, 937-948.
66. Zhang X., Liu S., Hu T., He Y. and Sun S. (2009). Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 50, 490-499.
67. Zhao J.J., Lin J., Yang H., Kong W., He L., Ma X., Coppola D. and Cheng J.Q. (2008). MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J. Biol. Chem. 283, 31079-31086.
68. Zheng T., Wang J., Chen X. and Liu L. (2010). Role of microRNA in anticancer drug resistance. Int. J. Cancer 126, 2-10.